---
title: 'Prognostic value of liver metastases in colorectal cancer treated by systemic
  therapy: An ARCAD pooled analysis'
date: '2024-06-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38896997/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240620182206&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: LM is a poor prognostic factor for mCRC increasing from
  1 L to ≥ 3 L except for patients in 1 L and 2 L receiving CT+anti-EGFR. These data
  justify using LM as a stratification factor in future trials for patients with unresectable
  ...'
disable_comments: true
---
CONCLUSION: LM is a poor prognostic factor for mCRC increasing from 1 L to ≥ 3 L except for patients in 1 L and 2 L receiving CT+anti-EGFR. These data justify using LM as a stratification factor in future trials for patients with unresectable ...